Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F20TT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $174,131
Award facts
- Contract value 100% obligated
- $174,131.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $174,131.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of January 15, 2026. This non-set-aside contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031. The IDC serves as a comprehensive pharmaceutical supply vehicle enabling the delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. Performance of this order will be conducted at the contractor's facility in Conshohocken, Pennsylvania.
Dupixent (dupilumab) is a biologic immunosuppressant commonly prescribed for moderate-to-severe atopic dermatitis, eosinophilic asthma, and other inflammatory conditions. This procurement supports the Defense Health Agency and other federal healthcare systems' pharmaceutical supply needs. AmerisourceBergen, as one of the nation's largest pharmaceutical distributors, routinely competes on a full and open basis for federal medical supply contracts and demonstrates established capability to meet DLA requirements through its extensive portfolio of federal contract awards across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F20TT?
SPE2DR26F20TT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F20TT worth?
The government has obligated $174,131 on SPE2DR26F20TT.
Is contract SPE2DR26F20TT an order under another contract?
Yes. SPE2DR26F20TT is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20TT competed?
The extent of competition for SPE2DR26F20TT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award